These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3074627)

  • 1. The effect of thymic substances on T circulating cells of patients treated for Hodgkin's disease.
    Chisesi T; Capnist G; Rancan L; Pellizzari G; Vespignani M
    J Biol Regul Homeost Agents; 1988; 2(4):193-8. PubMed ID: 3074627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets.
    Cooper KD; Kang K; Hanifin JM
    Diagn Immunol; 1983; 1(3):211-5. PubMed ID: 6388971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G; Santoro A; Bonfante V; Valagussa P
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
    Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
    Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients.
    Munno I; Pellegrino NM; Fumo G; Barbieri G; Polimeno G; de Filippis V; Jirillo E
    Cytobios; 1987; 52(210-211):167-73. PubMed ID: 3123147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related thymic activity in adults following chemotherapy-induced lymphopenia.
    Sfikakis PP; Gourgoulis GM; Moulopoulos LA; Kouvatseas G; Theofilopoulos AN; Dimopoulos MA
    Eur J Clin Invest; 2005 Jun; 35(6):380-7. PubMed ID: 15948899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
    Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
    J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of purine nucleotide metabolizing enzymes in human thymocytes and peripheral blood T lymphocytes: in vitro effect of thymic hormones.
    Ramagopal S; Reem GH
    Thymus; 1982 May; 4(3):163-72. PubMed ID: 6287680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cunningham J; Mauch P; Rosenthal DS; Canellos GP
    Cancer Treat Rep; 1982 Apr; 66(4):1015-22. PubMed ID: 7074629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of monoclonal antibodies in the diagnosis and monitoring of patients with primary immunodeficiencies: combined experience in three clinical immunology centers.
    Aiuti F; Quinti I; Seminara R; Sirianni MC; Vierucci A; Abo T; Cooper MD
    Diagn Immunol; 1983; 1(3):188-94. PubMed ID: 6388970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
    DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
    Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
    Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
    J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.